ARCHIVES

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Includes May issue of Business & Regulatory Report.

May 31, 2002

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

In Brief: Breast Cancer Detection Concept Was For Grants, Not Contracts; Wallens Gets Five Years Probation

November 16, 1984

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

NCI to Fund 122 More Grants in FY04

March 28, 2003